BACKGROUND: The aim of this study was to evaluate the prognostic impact of quantitative estrogen receptor (ER) expression at relapse for ER-positive breast cancer with ER-positive recurrence. PATIENTS AND METHODS: A total of 81 patients with ER-positive primary breast cancer and ER-positive paired recurrence were included. ER expression was evaluated as the percentage of tumor cells staining for ER under immunohistochemistry. Samples were defined as ER-high (ER>50%) or ER-low (ER≥10% and ≤50%). RESULTS: Quantitative ER expression on relapse biopsy was an independent prognostic factor for overall survival in multivariate analysis, both as a continuous (hazard ratio=0.8; 95% confidence interval=0.7-0.92, p=0.001) and as a categorical (ER-high vs. ER-low; hazard ratio=0.26; 95% confidence interval=0.11-0.59, p=0.001) variable. Patients whose status changed from ER-high (primary BC) to ER-low (relapse) had the poorest outcome, with a 10-year overall survival rate of 14%. CONCLUSION: Even in the case of maintenance of ER-positivity on primary and relapse of breast cancer, recurrence biopsy provides prognostic information.

Quantitative expression of estrogen receptor on relapse biopsy for ER-positive breast cancer: prognostic impact / Dieci, Maria Vittoria; Piacentini, Federico; Dominici, Massimo; Omarini, Claudia; Goubar, Aicha; Ficarra, Guido; Conte, Pierfranco; Guarneri, Valentina. - In: ANTICANCER RESEARCH. - ISSN 0250-7005. - ELETTRONICO. - 34:7(2014), pp. 3657-3662.

Quantitative expression of estrogen receptor on relapse biopsy for ER-positive breast cancer: prognostic impact

DIECI, Maria Vittoria;PIACENTINI, Federico;DOMINICI, Massimo;OMARINI, Claudia;CONTE, Pierfranco;GUARNERI, Valentina
2014

Abstract

BACKGROUND: The aim of this study was to evaluate the prognostic impact of quantitative estrogen receptor (ER) expression at relapse for ER-positive breast cancer with ER-positive recurrence. PATIENTS AND METHODS: A total of 81 patients with ER-positive primary breast cancer and ER-positive paired recurrence were included. ER expression was evaluated as the percentage of tumor cells staining for ER under immunohistochemistry. Samples were defined as ER-high (ER>50%) or ER-low (ER≥10% and ≤50%). RESULTS: Quantitative ER expression on relapse biopsy was an independent prognostic factor for overall survival in multivariate analysis, both as a continuous (hazard ratio=0.8; 95% confidence interval=0.7-0.92, p=0.001) and as a categorical (ER-high vs. ER-low; hazard ratio=0.26; 95% confidence interval=0.11-0.59, p=0.001) variable. Patients whose status changed from ER-high (primary BC) to ER-low (relapse) had the poorest outcome, with a 10-year overall survival rate of 14%. CONCLUSION: Even in the case of maintenance of ER-positivity on primary and relapse of breast cancer, recurrence biopsy provides prognostic information.
2014
34
7
3657
3662
Quantitative expression of estrogen receptor on relapse biopsy for ER-positive breast cancer: prognostic impact / Dieci, Maria Vittoria; Piacentini, Federico; Dominici, Massimo; Omarini, Claudia; Goubar, Aicha; Ficarra, Guido; Conte, Pierfranco; Guarneri, Valentina. - In: ANTICANCER RESEARCH. - ISSN 0250-7005. - ELETTRONICO. - 34:7(2014), pp. 3657-3662.
Dieci, Maria Vittoria; Piacentini, Federico; Dominici, Massimo; Omarini, Claudia; Goubar, Aicha; Ficarra, Guido; Conte, Pierfranco; Guarneri, Valentin...espandi
File in questo prodotto:
File Dimensione Formato  
Dieci Anticancer res 2014.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 148.42 kB
Formato Adobe PDF
148.42 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1118054
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 8
social impact